PRNewsWire
06 Aug 2026, 22:51 UTC · 10w ago
PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit
Impact · against what's priced in
PROCEPT BioRobotics faces significant valuation risk following allegations of systemic revenue manipulation and a massive field inventory glut. The claim that 10,000 excess units were pushed to customers to artificially inflate 2025 guidance suggests that future revenue will be severely depressed as customers draw down existing stock.
- PRCT−0.80
No priced-in read yet





